# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Pancreatic cancer 4

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 12 results.
Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
Status: Recruiting
Last Changed: Jan 25, 2019
First Received: May 15, 2018
Disease(s): Pancreatic Cancer
Intervention(s): Liquid Biopsy
Locations: St Vincent university Hospital, Dublin, Ireland
Policlinico Universitario Agostino Gemelli, Roma, Italy
AOU Sant'Andrea - UOC Chirurgia Generale, Roma, Italy
Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
Status: Recruiting
Last Changed: Mar 27, 2020
First Received: Mar 27, 2020
Disease(s): Locally Advanced and Metastatic Pancreatic Cancer
Intervention(s): PD-L1/CTLA4 BsAb, GP, FOLFIRINOX
Locations: Changhai hospital, Shanghai, Shanghai, China
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Status: Recruiting
Last Changed: Mar 13, 2020
First Received: May 15, 2017
Disease(s): Pancreatic Cancer
Intervention(s): Cyclophosphamide, GVAX, Pembrolizumab, IMC-CS4
Locations: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Status: Recruiting
Last Changed: Feb 07, 2020
First Received: Feb 27, 2017
Disease(s): Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer, Pancreatic Cancer
Intervention(s): Palbociclib, Gedatolisib
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
Status: Recruiting
Last Changed: May 05, 2020
First Received: Jan 25, 2019
Disease(s): Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8, Stage IIB Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma
Intervention(s): Anetumab Ravtansine, Gemcitabine Hydrochloride, Ipilimumab, Nivolumab
Locations: University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Siteman Cancer Center-South County, Saint Louis, Missouri, United States
... and 7 other locations.
Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer
Status: Not yet recruiting
Last Changed: Mar 19, 2020
First Received: Mar 19, 2020
Disease(s): Exocrine Pancreatic Insufficiency (EPI)
Intervention(s): CREON
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
Status: Recruiting
Last Changed: Apr 09, 2020
First Received: Feb 21, 2019
Disease(s): Melanoma, Cervical Carcinoma, Pancreatic Carcinoma, Triple Negative Breast Cancer, Hepatocellular Carcinoma, Urothelial Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Nasopharyngeal Carcinoma, Renal Cell Carcinoma, Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma, Gastric or Gastroesophageal Junction Adenocarcinoma, Advanced or Metastatic Solid Tumors, Prostate Carcinoma, MSI-H, Mismatch Repair Deficiency, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Intrahepatic Cholangiocarcinoma
Intervention(s): XmAb®22841, Pembrolizumab (Keytruda®)
Locations: UCLA Hematology & Oncology Clinic, Los Angeles, California, United States
Emory University Hospital Midtown, Atlanta, Georgia, United States
Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
... and 17 other locations.
Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer
Status: Not yet recruiting
Last Changed: Apr 10, 2020
First Received: Nov 26, 2019
Disease(s): Metastatic Pancreatic Cancer
Intervention(s): Cemiplimab, Plerixafor
Locations: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer
Status: Not yet recruiting
Last Changed: Apr 08, 2020
First Received: Oct 07, 2019
Disease(s): Colorectal Cancer, Pancreatic Cancer
Intervention(s): KRAS peptide vaccine, Nivolumab, Ipilimumab
Locations: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Intravenous Melphalan, BCNU, Vitamin B12b, Vitamin C, Ethanol, and Stem Cell Infusion in Pancreatic Cancer With an Inherited BRCA Mutation
Status: Not yet recruiting
Last Changed: Nov 04, 2019
First Received: Nov 04, 2019
Disease(s): Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation
Intervention(s): Melphalan, BCNU, Vitamin B12B, Vitamin C, Ethanol, CliniMACS-Enriched CD34+ Autologous Hematopoietic Stem Cells